Off-label drug use
Dooley, A.G.
Medicine and Health Rhode Island 90(2): 63-65
2007
ISSN/ISBN: 1086-5462 PMID: 17500258 Document Number: 605239
Document emailed within 1 workday
Related Documents
Martin, R.M.; Wilton, L.V.; Mann, R.D.; Steventon, P.; Hilton, S.R. 1998: Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off label Bmj 317(7152): 204Howard, P.; Copland, J. 2013: Off-label, not off-limits: the FDA needs to create a safe harbor for off-label drug use Missouri Medicine 110(2): 106-109
Leung, T.I.; Dumontier, M. 2015: Comparing Drug-Disease Associations in Clinical Practice Guideline Recommendations and Drug Product Label Indications Studies in Health Technology and Informatics 216: 1039
Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Bavdekar, S.B.; Gogtay, N.J. 2005: Unlicensed and off-label drug use in children Journal of Postgraduate Medicine 51(4): 249-252
Rane, A. 2006: Drug committees should not recommend "off label" prescriptions Lakartidningen 103(15-16): 1219
Butcher, L. 2009: When should insurers cover off-label drug usage? Managed Care 18(5): 40-42
Bouvenot, G.; Juillet, Y.; Saint-Pierre, A. 2019: Off-label drug use in France: recommendations of the academies of medicine and pharmacy La Revue du Praticien 69(2): 129-131
Mehdi, A.; Bokhari, S.A.; Yousuf, N.; Umerani, A.; Chughtai, S.; Hussain, F.; Raza, A. 1992: A novel triple label method validates the double label technique of defining cell cycle kinetics in HL-60 cells Anticancer Research 12(5): 1443-1446
Conroy, S. 1998: Unlicensed and off label drug use for paediatric patients. Optimal dosing schedules with gentamicin are needed for premature neonates Bmj 317(7152): 204-205
Starling, J.J.; Hinson, N.A.; Marder, P.; Maciak, R.S.; Laguzza, B.C.; Corvalan, J.R.; Smith, W. 1988: Development of a dual label fluorescence technique that can be utilized to elucidate the mechanism of action of monoclonal antibody-drug conjugates Cancer Research 48(21): 6211-6216
Hart, B.L.; Cliff, K.D. 1996: Interpreting published results of extra-label drug use with special reference to reports of drugs used to correct problem behavior in animals Journal of the American Veterinary Medical Association 209(8): 1382-1385
Groleger, U. 2007: Off-label use of antipsychotics: rethinking "off-label" Psychiatria Danubina 19(4): 350-353
Lua, P.L.; Talib, N.S. 2013: Auricular acupuncture for drug dependence: an open-label randomized investigation on clinical outcomes, health-related quality of life, and patient acceptability Alternative Therapies in Health and Medicine 19(4): 28-42
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
McAlevey, M. 2011: Off-label treatment New Zealand Medical Journal 124(1338): 131; Author Reply 131-2
Cleland, K.; Wood, S. 2014: A tale of two label changes Contraception 90(1): 1-3
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Fanconi, S.; Barazzone Argiroffo, C. 2009: Off-label use of drugs in pediatrics Revue Medicale Suisse 5(191): 387
Lunderquist, B. 1994: Why not an "information label" for physicians? Lakartidningen 91(16): 1590